Bibliographic Details
Title: |
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer |
Authors: |
Kai C. C. Johnson, Ai Ni, Dionisia Quiroga, Ashley C. Pariser, Preeti K. Sudheendra, Nicole O. Williams, Sagar D. Sardesai, Mathew Cherian, Daniel G. Stover, Margaret Gatti-Mays, Bhuvaneswari Ramaswamy, Maryam Lustberg, Sachin Jhawar, Roman Skoracki, Robert Wesolowski |
Source: |
npj Breast Cancer, Vol 10, Iss 1, Pp 1-8 (2024) |
Publisher Information: |
Nature Portfolio, 2024. |
Publication Year: |
2024 |
Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
More Details: |
Abstract There is limited data regarding the added benefit of adjuvant systemic therapy in the management of small, node-negative, HER2+ breast cancer. In a multi-institutional retrospective analysis using the American Society of Clinical Oncology CancerLinQ database, we compared survival outcomes among T1a-c N0 HER2+ patients diagnosed between 2010 to 2021 who received locoregional therapy alone or in combination with adjuvant trastuzumab (+/− chemotherapy). Primary outcomes were invasive disease-free survival (iDFS) and overall survival (OS). Of the 1,184 patients, 436 received locoregional therapy alone. We found a statistically significant improvement in iDFS (HR 0.73, P = 0.003) and OS (HR 0.63, P = 0.023) on univariate analysis with adjuvant trastuzumab with or without chemotherapy which remained statistically significant on multivariate analysis. Three-arm univariate analysis found that iDFS was significantly improved with trastuzumab monotherapy (P = 0.003) and combination therapy (P = 0.027) compared to observation. Subgroup data suggests that T1b/c tumors derive the greatest benefit. |
Document Type: |
article |
File Description: |
electronic resource |
Language: |
English |
ISSN: |
2374-4677 |
Relation: |
https://doaj.org/toc/2374-4677 |
DOI: |
10.1038/s41523-024-00652-4 |
Access URL: |
https://doaj.org/article/fc9fb37c438d44728b8717088153f8ae |
Accession Number: |
edsdoj.fc9fb37c438d44728b8717088153f8ae |
Database: |
Directory of Open Access Journals |